Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors

E. K. Rowinsky, L. B. Grochow, S. E. Sartorius, M. K. Bowling, S. H. Kaufmann, D. Peereboom, R. C. Donehower

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences